Recent Studies Highlight Ketogenic Diet's Potential Benefits for Depression and Diabetes
Recent studies have highlighted the potential benefits of the ketogenic diet in managing treatment-resistant depression and type 2 diabetes. The ketogenic diet, characterized by low carbohydrate intake and high fat consumption, aims to induce ketosis, where the body burns fat for energy instead of carbohydrates. A study published in JAMA Psychiatry in February 2026 examined 88 participants aged 18 to 65 with treatment-resistant depression. Participants were randomly assigned to follow either a ketogenic diet, limited to 30 grams of carbohydrates per day, or a phytochemical control diet over six weeks. After this period, participants returned to their usual diets, and follow-up assessments after 12 weeks indicated that those on the ketogenic diet experienced a greater reduction in their depression scores, dropping by about 10 points compared to an 8-point drop in the control group. Lead author Min Gao, PhD, emphasized that while the findings are promising, the ketogenic diet should not be seen as a cure for depression, noting its challenges in adherence and the importance of continuing current treatment recommendations. Another study published in Nature Communications in February 2026 investigated the effects of a ketogenic diet on blood sugar control in mice. The research involved mice with induced high blood sugar, some of which were placed on a ketogenic diet while others remained on a standard diet. The results showed that the mice on the ketogenic diet reverted to normal blood sugar levels, and those that also underwent exercise training exhibited enhanced benefits. Study author Sarah Lessard, PhD, pointed out that the combination of a ketogenic diet and exercise improved aerobic capacity in the mice. However, experts caution about the sustainability of such a diet. Kristin Kirkpatrick, MS, RDN, highlighted the importance of long-term adherence to any dietary pattern for success. A third study published in the Journal of the Endocrine Society in April 2026 focused on humans, revealing that a ketogenic diet may be more effective than a low-fat diet in achieving remission from type 2 diabetes. This trial involved 51 participants aged 35 to 65 diagnosed with type 2 diabetes, who followed either a ketogenic or low-fat diet for 12 weeks. While all participants lost weight, only those on the ketogenic diet showed a significant decrease in proinsulin levels, indicating improved beta-cell function. Study author Marian Yurchishin, MS, explained that lower proinsulin levels suggest reduced stress on beta-cells, which are crucial for insulin production. Despite these findings, experts continue to question the long-term sustainability of the ketogenic diet, emphasizing the need for further research to explore its long-term effects and mechanisms.




